Effect of early enteral combined with parenteral nutrition in patients undergoing pancreaticoduodenectomy

doi:10.3748/wjg.v19.i35.5889

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 35

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6072)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-7) series.

Item

Count

PDF

561

HTML

3352

Tables (1-7)

154

Sum=4067

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1060

Download

945

Sum=2005

Sep 21, 2013 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 21, 2013; 19(35): 5889-5896
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5889

Table 1 Ranges and averages of calories, protein, fat and carbohydrates in the enteral and parenteral regimens in the early enteral nutrition/parenteral nutrition group

POD	Nutritional support	Calories (kJ)	Protein (g)	Fat (g)	Carbohydrates (g)
1	PN	7649.4 (6081.9-10282.8)	91.5 (72.8-123.0)	67.1 (53.3-90.2)	305.0 (242.5-410.0)
	EN	83.6	0	0	5
2	PN	7649.4 (6081.9-10282.8)	91.5 (72.8-123.0)	67.1 (53.3-90.2)	305.0 (242.5-410.0)
	EN	418	0	0	25
3	PN	6447.6 (4880.1-9081.0)	84.0 (65.3-115.5)	59.6 (45.8-82.7)	257.5 (195.0-362.5)
	EN	1201.8	7.5	7.5	47.5
4	PN	5559.4 (3991.9-8192.8)	76.5 (57.8-108.0)	52.1 (38.3-75.2)	235.0 (172.5-340.0)
	EN	2090	15	15	70
5	PN	3469.0 (1901.9-6102.8)	61.5 (42.8-93.0)	37.1 (23.3-60.2)	165.0 (102.5-270.0)
	EN	4180	30	30	140
6	PN	0	0	0	0
	EN	7649.4 (6081.9-10282.8)	54.9 (43.65-73.8)	54.9 (43.65-73.8)	256.2 (203.7-344.4)

Data are expressed as absolute average or average (range). POD: Post-operation day; PN: Parenteral nutrition; EN: Enteral nutrition.

Table 2 Preoperative clinical data, intraoperative factors and histopathology of the patients enrolled in the study

	TPN group	EEN/PN group
Sex (male/female)	44/23	70/37
Age (yr)	52. 8 ± 11.2	53.9 ± 10.6
Intraoperative factors	52. 8 ± 11.2	53.9 ± 10.6
Patients with jaundice (%)	79.1	83.2
Patients with preoperative ENBD (%)	50.7	48.6
Preoperative hemoglobin (g/L)	11.8 ± 1.0	12.4 ± 0.8
Preoperative albumin (g/L)	37.9 ± 3.1	36.8 ± 3.6
Duration of surgery (min)	345.1 ± 64.8	332.7 ± 56.6
Operative blood loss (mL)	648.4 ± 262.6	680.2 ± 193.7
Blood transfusion (%)	26.9	31.7
Histopathologic finding (n)
Pancreatic head carcinoma	24	37
Distal cholangiocarcinoma	19	31
Periampullary adenocarcinoma	21	34
Duodenal adenocarcinoma	3	5

EEN: Early enteral nutrition; ENBD: Endoscopic nasal biliary drainage; PN: Prognostic nutritional; TPN: Total parenteral nutrition.

Table 3 Comparison of nutrition-associated assessment in the two groups (mean ± SD)

	Normal value	Group	Day 1	Day 6	Decrease (days 1-6)
TP (g/L)	62-85	TPN	63.46 ± 7.24	59.92 ± 7.65	3.54 ± 1.72
		EEN/PN	64.11 ± 6.84	61.12 ± 6.83	2.99 ± 1.07
PAB (mg/L)	0-800	TPN	196.25 ± 64.32	116.52 ± 72.16^a	79.73 ± 35.32
		EEN/PN	190.15 ± 62.18	158.32 ± 62.46	31.83 ± 13.15^c
TF (g/L)	2.2-12	TPN	2.53 ± 0.76	2.20 ± 0.72	0.33 ± 0.61
		EEN/PN	2.46 ± 0.68	2.08 ± 0.81	0.38 ± 0.72
PNI	> 50	TPN	50.36 ± 9.14	43.12 ± 8.13	7.24 ± 7.40
		EEN/PN	51.62 ± 8.16	45.15 ± 9.52	6.47 ± 5.93
N-balance (g/d)		TPN	/	-(14.76 ± 6.03)	/
		EEN/PN	/	-(15.91 ± 7.85)	/

^aP < 0.05 vs day 1;

^cP < 0.05 vs total parenteral nutrition (TPN) group. PAB: Prealbumin; PNI: Prognostic nutritional index; TP: Total protein; TF: Transferrin; EEN: Early enteral nutrition; PN: Parenteral nutrition.

Table 4 Comparison of liver function in the two groups (mean ± SD)

	Normal value	Group	Day 1	Day 6	Decrease (days 6-1)
ALT (μ/L)	5-40	TPN	138.2 ± 48.4	82.5 ± 42.3^a	55.7 ± 31.5
		EEN/PN	145.1 ± 39.2	77.4 ± 37.6^a	67.7 ± 36.2
AST (μ/L)	8-40	TPN	97.6 ± 36.2	55.1 ± 31.5^a	42.5 ± 26.2
		EEN/PN	102.3 ± 41.3	63.2 ± 36.3^a	39.1 ± 22.0
TB (μmol/L)	5-20.5	TPN	112.5 ± 37.5	66.2 ± 29.4^a	46.3 ± 34.3
		EEN/PN	106.8 ± 36.2	41.5 ± 34.1^b	65.3 ± 36.2^c
DB (μmol/L)	1.7-6.8	TPN	78.6 ± 30.2	38.1 ± 26.2^a	40.5 ± 21.3
		EEN/PN	81.7 ± 35.6	22.4 ± 16.2^b	59.3 ± 28.1^c
LDH (μ/L)	109-245	TPN	332.6 ± 89.4	264.3 ± 101.3^a	68.3 ± 51.2
		EEN/PN	316.2 ± 98.1	211.5 ± 86.2^a	104.7 ± 76.8^c

^aP < 0.05,

^bP < 0.01 vs day 1;

^cP < 0.05 vs total parenteral nutrition (TPN) group. PN: Prognostic nutritional; EEN: Early enteral nutrition; TB: Total bilirubin.

Table 5 Predictive risk score of major complications after pancreaticoduodenectomy in the two groups

Predictor	Categories	Risk Score	TPN group	EEN/PN group
Pancreatic texture (%)	Hard	0	43	73
	Soft	4	24	34
Pancreatic duct diameter (%)	> 3 mm	0	48	81
	≤ 3 mm	1	19	26
Operative blood loss (%)	< 700 mL	0	55	81
	≥ 700 mL	4	12	26
ASA score (%)	I	0	31	55
	II	2	33	47
	III	6	3	5
Score categorized in 4 risk classes n (%)	0-3		23 (34.3)	38 (35.5)
	4-7		22 (32.8)	33 (30.8)
	8-11		19 (28.4)	31 (29.0)
	12-15		3 (4.5)	5 (4.7)

ASA: American Society of Anesthesiologist; EEN: Early enteral nutrition; TPN: Total parenteral nutrition; PN: Prognostic nutritional.

Table 6 Postoperative outcome in the two groups n (%)

Group	TPN group	EEN/PN group
Complication Grade
No complications	24 (35.8)	42 (39.2)
I	33 (49.3)	38 (35.5)^a
II	38 (56.7)	42 (39.3)^a
IIIa	7 (10.4)	10 (9.3)
IIIb	4 (6.0)	5 (4.6)
IVa	0 (0.0)	0 (0.0)
IVb	0 (0.0)	0 (0.0)
V (mortality)	0 (0.0)	0 (0.0)
Reoperation	3 (4.5)	6 (5.6)
Readmission	2 (3.0)	3 (2.8)
Postoperative hospital stay (d)	16.8 ± 6.2	13.2 ± 4.7^a

Numbers of single types of complications do not add up to the number of patients within the 2 groups, due to the possible occurrence of more types of complications in some patients.

^aP < 0.05 vs total parenteral nutrition (TPN) group. EEN: Early enteral nutrition; PN: Prognostic nutritional.

Table 7 Postoperative complications in the two groups n (%)

Complications	TPN group	EEN/PN group
Pancreatic fistula	2 (3.0)	4 (3.7)
Grade A	0 (0.0)	0 (0.0)
Grade B	2 (3.0)	4 (3.7)
Grade C	0 (0.0)	0 (0.0)
Wound infection	8 (11.9)	10 (9.3)
Abdominal abscess	7 (10.4)	6 (5.6)
Bile leak	5 (7.5)	7 (6.5)
Cholangitis	4 (6.0)	3 (2.8)
Urinary tract infection	5 (7.5)	6 (5.6)
Pneumonia	8 (11.9)	6 (5.6)
Catheter-related sepsis	0 (0.0)	0 (0.0)
Gastrointestinal bleeding	4 (6.0)	5 (4.7)
Intraperitoneal bleeding	3 (4.5)	6 (5.6)
Delayed gastric emptying	11 (16.4)	6 (5.6)
Enteral-feeding-related complications	0 (0.0)	29 (27.1)
Abdominal cramps	0 (0.0)	6 (5.6)
Abdominal distention	0 (0.0)	11 (10.3)
Diarrhea	0 (0.0)	9 (8.4)
Vomiting	0 (0.0)	3 (2.8)
Hyperglycemia	12 (17.9)	6 (5.6)

Numbers of single types of complications do not add up to the number of patients within the 2 groups, due to the possible occurrence of more types of complications in some patients. EEN: Early enteral nutrition; PN: prognostic nutritional; TPN: Total parenteral nutrition.

Citation: Zhu XH, Wu YF, Qiu YD, Jiang CP, Ding YT. Effect of early enteral combined with parenteral nutrition in patients undergoing pancreaticoduodenectomy. World J Gastroenterol 2013; 19(35): 5889-5896
URL: https://www.wjgnet.com/1007-9327/full/v19/i35/5889.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i35.5889